The Jill Roberts Center for Inflammatory Bowel Disease

Our Mission

To provide our patients with the highest standard of personalized care, while seeking new therapies as an internationally recognized center for innovative IBD research.

About our Program

Welcome to the Jill Roberts Center for Inflammatory Bowel Disease (JRC). We are one of the nation’s leading multidisciplinary centers for the diagnosis, comprehensive care and innovative treatment of patients with IBD.

We offer integrated clinical services from the NewYork-Presbyterian Hospital/Weill Cornell Medicine network, including access to IBD-focused surgeons, pediatricians, rheumatologists, and hepatologists, as well as cutting edge clinical trials that aim to treat and prevent the progression of Crohn’s disease and colitis. 

Building on the delivery of comprehensive care, we are committed to improving the lives of patients and families by developing unique clinical services, including a dedicated IBD nutrition program, IBD-related joint assessment, and IBD-focused genetic testing and counseling, and dysplasia/colorectal cancer screening and surveillance programs.

Come explore the unique programs and personalized care that the JRC can offer in comprehensive IBD care!

We hope that this website serves as a fitting introduction to our staff and clinical services.

Continue reading more About Us

Unique Programs and Personalized Care at the JRC

Multi-disciplinary IBD Medicine-Surgery Clinic.  Crohn’s disease and colitis require coordination of care from multiple disciplines of both medicine and surgery.  The JRC offers a unique opportunity for patients with both medical and surgical needs to schedule joint consultation with an IBD-focused surgeon and gastroenterologist.  This unique multi-disciplinary consultation seamlessly coordinates complex care and provides focused support for IBD patients.

Precision medicine in IBD.  Weill Cornell is leading the effort to understand how to develop and use IBD medicines more safely and effectively.  Every patient in our practice has the opportunity to participate in research to directly address these issues.  Learn more about research opportunities at the JRC.

IBD-related joint inflammation.  Joint inflammation is one of the most common symptoms associated with active IBD.  Our research team has teamed up with rheumatologist at the Hospital for Special Surgery to develop novel criteria to evaluate and help treat IBD patients with joint symptoms.  Please contact us to setup your evaluation.

Clinical trials at the JRC.  Despite the improvement in medications, many patients with IBD have inflammation that is refractory to standard therapy.  The JRC is one the nation’s leading centers in helping to test new emerging therapies for the treatment of IBD.  Learn more about these studies here.

IBD nutrition program. Nutritional assessment and guidance is a cornerstone of comprehensive IBD care.  Ryan Warren, M.S., R.D.N, C.D.N. leads our nutrition program tailored to support patients with IBD.  Learn more about the nutritional support programs.

Advanced IBD fellowship at Weill Cornell Medicine

The Advanced Fellowship in IBD is designed for candidates following successful completion of an ACGME-accredited fellowship program in gastroenterology and hepatology.  The goal of the one year fellowship will be to prepare one fellow annually for independent practice as a gastroenterologist specializing in the care of patients with IBD.  Emphasis will be placed on knowledge of inpatient and outpatient management of both average risk and complicated IBD, development of clinical and/or translation research programs, and mentorship towards a goal of establishment of a successful academic IBD clinical practice.  Download application here.

Meet the Director

Make an Appointment

(212) 746-5077

Weill Cornell Connect

Map this location

Jill Roberts Center for Inflammatory Bowel Disease
NewYork-Presbyterian Hospital
Weill Cornell Medical Center
1283 York Avenue
9th Floor
New York, NY 10065

The Jill Roberts Institute for Research in Inflammatory Bowel Disease

2020 JRC Annual Report